Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time.
about
Effects of polyethylene glycol spacer length and ligand density on folate receptor targeting of liposomal Doxorubicin in vitroFolate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migrationNanoparticle mediated drug delivery of rolipram to tyrosine kinase B positive cells in the inner ear with targeting peptides and agonistic antibodies.Effects of tail-like substituents on the binding of competitive inhibitors to the Q(B) site of photosystem II.Lectin-functionalized liposomes for pulmonary drug delivery: interaction with human alveolar epithelial cells.The effect of RMP-7 and its derivative on transporting Evans blue liposomes into the brain.Drug transport to brain with targeted liposomesNanopharmacology in translational hematology and oncologyNew sterically stabilized vesicles based on nonionic surfactant, cholesterol, and poly(ethylene glycol)-cholesterol conjugates.Characterization of spherulites as a lipidic carrier for low and high molecular weight agentsThe role of flexible tethers in multiple ligand-receptor bond formation between curved surfaces.Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides.Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution.Inside-outside self-assembly of light-activated fast-release liposomes.Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts.Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumorUltrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes.Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in ratsSpecific and reversible DNA-directed self-assembly of oil-in-water emulsion dropletsPEGylation as a strategy for improving nanoparticle-based drug and gene deliveryPost-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo.Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriersAntibody-based therapeutics for the treatment of human B cell malignanciesImaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots.Effect of the lipid chain melting transition on the stability of DSPE-PEG(2000) micelles.Nanoparticles evading the reticuloendothelial system: role of the supported bilayer.Surface engineering of liposomes for stealth behavior.Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances.Bone marrow-targeted liposomal carriersMerging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.Ligation strategies for targeting liposomal nanocarriers.Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions.Effect of ligand density and PEG modification on octreotide-targeted liposome via somatostatin receptor in vitro and in vivo.Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models.Boronic acid-modified lipid nanocapsules: a novel platform for the highly efficient inhibition of hepatitis C viral entry.Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma.Starch-coated magnetic liposomes as an inhalable carrier for accumulation of fasudil in the pulmonary vasculature.Down-regulated lysosomal processing improved pegylated lipopolyplex-mediated gene transfection.Efficient intracellular delivery of siRNA with a safe multitargeted lipid-based nanoplatform.Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension.
P2860
Q28741592-ECB6C4C3-4C8C-4C99-8DFF-DD3373F5F6D4Q28829561-4AF1DBAC-4766-4C17-8240-26BF1B731C61Q30409983-3BA59F9A-DE9A-4871-8658-EF5F852C572DQ30674814-DCF39307-FA34-4EA5-8A2D-D2A14DBC1CDAQ31028618-60D07EC7-546F-4F23-8F33-0DA862F45DD2Q31150807-9518B078-B6F7-4AA2-84C2-E8F8ECCC1E23Q33569479-F08A1F28-B778-403A-B63E-686187653769Q33961538-2E0DABD3-4986-4304-B4F5-985CECA1AD76Q34168201-1A159827-1C64-4C43-AAA9-474B8602BDFFQ34665722-9A795CE9-7134-44F2-8F28-ABA8207E3F0BQ34984732-82F9337D-A7DE-4AA6-8D86-CE974E24635FQ35087556-1FFA23DF-F414-4E5F-AEA7-45A08BC9B81FQ35232986-74CA482C-F095-451B-9C4F-3A417952F9CFQ35569895-BC84F4BF-3504-4F16-8DC6-495FD97AB68CQ35613017-948A6D77-8EDE-43FE-9BDA-627915C21722Q35785890-7488F969-8A3B-4A8E-A996-B871FC346577Q35979160-FB5F7458-E393-4AF3-9F5E-75A23AC3DF3DQ36148614-C331F0DA-11C0-4072-9B3D-CF6B60358BA5Q36483869-3CE612B2-35FF-4061-97C5-DF20D125DFE3Q36703361-9AF1FDDF-87C8-493B-9CD0-77815CC2CD95Q36792020-8EA4661A-8374-4570-A300-811D654402D0Q36831931-8A62D2F1-135C-4ED7-8D37-D9C7B063A85BQ36907540-C587C0D3-7717-44EA-A0EF-7F157F139B4DQ37167336-02DEAC5E-B615-44B3-B74F-D443C1508E97Q37373619-95F11759-B144-4E5A-AEEC-9AF2DB7BC4EEQ37376443-6C2174CF-F85E-48E7-B68F-4C4E866D6A5CQ37415968-72570129-E223-4096-B45D-1EE5A70CB57AQ37805491-C59E5A00-0A31-4AB3-AFFF-A6096585E641Q37833107-D5145C58-6E18-43F8-B6A6-CA11FCFE3DBAQ38150118-C4E65597-CA71-487D-A50C-3AFA5E2E9E5BQ38240154-D6262F52-2523-45AB-9F0D-CD03BF8F6A49Q38288939-2F67FD30-35CD-44AC-9C71-B6CB80BF16FCQ38757086-F3CFE3BF-AABE-438A-8B5B-38F37D0B9728Q38818802-738027CF-8058-4369-A162-CACFBFA53A7BQ38928977-CEB73241-634A-4C4B-888E-C1CF416E0E05Q39113077-47A9B947-9B05-43C0-86A5-808F679E5359Q39139947-FC142ADC-F8D4-4CFD-9798-B38A7D573712Q39162653-D4F4CC4E-7428-4A5A-85F7-909DE2FEB935Q39197452-0880EA54-CCB5-4CE0-9297-F258BC815DCAQ39204011-AE165862-45F3-4FB5-A619-98F24AE97B3E
P2860
Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Insertion of poly(ethylene gly ...... nged in vivo circulation time.
@ast
Insertion of poly(ethylene gly ...... nged in vivo circulation time.
@en
type
label
Insertion of poly(ethylene gly ...... nged in vivo circulation time.
@ast
Insertion of poly(ethylene gly ...... nged in vivo circulation time.
@en
prefLabel
Insertion of poly(ethylene gly ...... nged in vivo circulation time.
@ast
Insertion of poly(ethylene gly ...... nged in vivo circulation time.
@en
P2093
P2860
P1433
P1476
Insertion of poly(ethylene gly ...... nged in vivo circulation time.
@en
P2093
P2860
P304
P356
10.1016/0014-5793(96)00452-8
P407
P577
1996-05-01T00:00:00Z